Interventional Glaucoma Case: iDose and iStent Infinite

Show Description +

I. Paul Singh, MD, shares what he says is the future of interventional glaucoma. The patient in this case underwent iDose implantation and it allowed him to be off topical PGA for 4 years. Last year, he began PGA again. He recently had a significant cataract and Dr. Singh decided to remove the iDose (since it was past its lifespan) and implant iStent infinite (Glaukos). The video shows the stability of the iDose during phacoemulsification and the ease of removal.

Financial Disclosure: Consultant (Glaukos)

Posted: 6/25/2024

Keywords:

iStent

iDose

Glaukos Corporation

Interventional Glaucoma Case: iDose and iStent Infinite

I. Paul Singh, MD, shares what he says is the future of interventional glaucoma. The patient in this case underwent iDose implantation and it allowed him to be off topical PGA for 4 years. Last year, he began PGA again. He recently had a significant cataract and Dr. Singh decided to remove the iDose (since it was past its lifespan) and implant iStent infinite (Glaukos). The video shows the stability of the iDose during phacoemulsification and the ease of removal.

Financial Disclosure: Consultant (Glaukos)

Posted: 6/25/2024

Keywords:

iStent

iDose

Glaukos Corporation

Please log in to leave a comment.

More in Glaucoma

Implementing Interventional Glaucoma Treatment Protocols

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; Deborah Ristvedt, DO; and Mark Gallardo, MD

Treatment Patterns and Patient Compliance

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; and Deborah Ristvedt, DO

Practice Assessment Results

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; Deborah Ristvedt, DO; and Mark Gallardo, MD

The Unmet Need for a Consensus Treatment Approach to Glaucoma

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; Deborah Ristvedt, DO; and Mark Gallardo, MD